Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Cortheraâ€™s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.
Past Team (6)Update
Caxton Advantage Life Science Fund is a New York-based financial firm that invests into companies...
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
Venture Capital Firm
150 Industrial Road
San Carlos, CA 94070